Literature DB >> 10378656

Radiotherapy for adrenal gland metastasis from lung cancer: report of three cases.

N Miyaji1, T Miki, Y Itoh, J Shimada, T Takeshita, H Churei, M Nakajo.   

Abstract

Adrenal gland metastasis is often observed during the clinical course of patients with lung cancer. However, treatment of adrenal gland metastasis is seldom considered because of the systemic spread of the disease. Treatment with curative intent is very rare, but palliative treatment may sometimes be considered when symptoms such as flank pain are observed. Three cases of adrenal gland metastasis were reported. Two of them received surgery for lung cancer and developed a sole metastasis of the adrenal gland. Case 1 developed a sole left adrenal gland metastasis with left flank pain 14 months after surgery for large cell carcinoma of the lung. Curative radiotherapy after intra-arterial chemotherapy was given. A good response was obtained, and he has been alive for 2 years and 9 months. Case 2 developed a right adrenal gland metastasis after radiotherapy for brain metastasis, after having received right upper lobectomy because of SCLC. The increase in the size of the right adrenal gland led us to treat the lesion before symptoms developed. Radiotherapy was given on an outpatient basis. Case 3, who was previously treated with chemoradiotherapy for SCLC, developed brain, liver, and bilateral adrenal gland metastasis. Huge adrenal gland metastases displaced the pancreas and caused severe pain with the increase in serum amylase level. Concurrent radiotherapy with systemic chemotherapy was given and remarkable shrinkage of the adrenal gland metastases was obtained together with pain relief. Cases 2 and 3 died after 8 and 4 months, respectively. In some cases, radiotherapy for adrenal gland metastasis is a good palliative therapy even in the advanced stage patients. Radiotherapy can sometimes curatively treat adrenal metastasis from NSCLC, as in our Case 1, in which adrenalectomy appeared difficult at the time of recurrence.

Entities:  

Mesh:

Year:  1999        PMID: 10378656

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  8 in total

Review 1.  Addisonian crisis secondary to bilateral adrenal metastases in rectal carcinoma: report of a rare case and literature review.

Authors:  Muhammad Shahid Iqbal; John Hardman
Journal:  J Gastrointest Cancer       Date:  2013-06

Review 2.  Adrenal incidentalomas: surgical treatment in 28 patients and update of the literature.

Authors:  A B Porcaro; G Novella; V Ficarra; P Curti; S Z Antoniolli; H S Suangwoua; G Malossini
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Stereotactic body radiation therapy (SBRT) for adrenal metastases : a feasibility study of advanced techniques with modulated photons and protons.

Authors:  Marta Scorsetti; Pietro Mancosu; Piera Navarria; Angelo Tozzi; Simona Castiglioni; Elena Clerici; Giacomo Reggiori; Francesca Lobefalo; Antonella Fogliata; Luca Cozzi
Journal:  Strahlenther Onkol       Date:  2011-03-25       Impact factor: 3.621

4.  Retroperitoneal hemorrhage due to bilateral adrenal metastases from lung adenocarcinoma.

Authors:  N Hiroi; R Yanagisawa; M Yoshida-Hiroi; T Endo; T Kawase; Y Tsuchida; K Toyama; K Shibuya; K Nakata; G Yoshino
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

5.  Robotic Radiosurgery for Adrenal Gland Metastases.

Authors:  Alfred Haidenberger; Sarah-Charlotta Heidorn; Nikolaus Kremer; Alexander Muacevic; Christoph Fürweger
Journal:  Cureus       Date:  2017-03-26

6.  Percutaneous interstitial brachytherapy for adrenal metastasis: technical report.

Authors:  Kazushi Kishi; Shinji Tamura; Yasushi Mabuchi; Tetsuo Sonomura; Yasutaka Noda; Motoki Nakai; Morio Sato; Kazuhiko Ino; Noboru Yamanaka
Journal:  J Radiat Res       Date:  2012-07-17       Impact factor: 2.724

7.  A Retrospective Review of CyberKnife Stereotactic Body Radiotherapy for Adrenal Tumors (Primary and Metastatic): Winthrop University Hospital Experience.

Authors:  Amishi Desai; Hema Rai; Jonathan Haas; Matthew Witten; Seth Blacksburg; Jeffrey G Schneider
Journal:  Front Oncol       Date:  2015-08-17       Impact factor: 6.244

8.  Incorporation of EGFR mutation status into M descriptor of new TNM classification influences survival curves in non-small cell lung cancer patients.

Authors:  Karmen Stanic; Nina Turnsek; Martina Vrankar
Journal:  Radiol Oncol       Date:  2019-11-20       Impact factor: 2.991

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.